Patient ID | Diagnosis | Age (years) | Gender | Disease duration (months) | Cumulative cortisone (mg) | Imuunosuppressive treatment at second biopsy | Autoantibodies | Support for diagnosis | MMT-8 (%) | s-CK (μcat/L) | HAQ (0.0–3.0) | FI-2 (%) | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B | A | B | A | B | A | B | A | |||||||||
1 | DM | 40 | M | 3 | 14450.0 | Pred, AZA | MDA5, SSA, Ro60 | MW, S, LD | 87.5 | 87.5 | 1.3 | 1.1 | 1.13 | 0.75 | 21.7 | 27.4 |
2 | PM | 73 | F | 12 | 6222.5 | Pred, MTX | Neg | MW, CK, MB | 85.0 | 85.0 | 10.2 | 1.5 | 0.5 | 0.88 | 18.3 | 19.1 |
3 | DM | 69 | F | 2 | 10017.5 | Pred, MTX | ANA, TIF1γ | MW, CK, S, EMG | 81.4 | 91.3 | 29.3 | 1.0 | 0.63 | 0 | 0 | 11.2 |
4 | DM | 63 | M | 0.5 | 7330.0 | Pred, AZA | Neg | MW, CK, S, EMG | 78.8 | 90.0 | 48.2 | 1.0 | 0,38 | 0 | 86.2 | 100.0 |
5 | DM | 45 | F | 16 | 6842.5 | Pred, MTX | ANA, Mi-2 | MW, CK, MB, S, EMG | 98.8 | 87.5 | 43.0 | 2.1 | 1.5 | 0.88 | 17.3 | 25.3 |
6 | PM | 71 | F | 12 | 8415.0 | Pred, AZA | Neg | MW, CK, MB | 75.7 | 100 | 9.0 | 3.9 | 1.25 | 1.88 | NA | 17 |